Free Trial

Abbott Laboratories (ABT) SEC Filings & 10K Form

$115.96
+1.33 (+1.16%)
(As of 10/9/2024 ET)

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
10/01/2024
4:27 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:33 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:39 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:48 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:24 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:20 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:52 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:02 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:39 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:35 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:59 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2024
3:02 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
5:05 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:11 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:16 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:22 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:29 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:54 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:00 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:43 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:48 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:33 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:38 PM
Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
5:50 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:58 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:32 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:40 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:09 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:14 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:18 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:22 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:56 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:00 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:05 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:39 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:44 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:50 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Bigger Than Nvidia? (Ad)

Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.

Go here now for this breaking story.
03/01/2024
4:53 PM
Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:39 PM
Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:45 PM
Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:22 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:25 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:32 PM
Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
5:13 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:45 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:35 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:38 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:40 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:43 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:27 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:29 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:33 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:23 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:03 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:15 PM
Abbott Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
4:30 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:04 PM
Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:38 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:28 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:30 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:33 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
4:36 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ABT) was last updated on 10/9/2024 by MarketBeat.com Staff
From Our Partners